Tweet by Michael Okun on Twitter telepsychiatry

YPbCAmgI_normal.jpg spacer.png
Michael Okun
⁦‪@MichaelOkun‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Can we agree tele-health for use in cognitive behavioral therapy for PD a good idea? I know debate of PD dx, however ACCESS benefits for intense therapy hard to match. New SMALL randomized pilot study positive; (depression, anxiety, apathy, QOL benefit). …mentdisorders.onlinelibrary.wiley.com/doi/epdf/10.10… pic.twitter.com/E6cuteu6Au
10/30/22, 8:04 AM

Joseph Thornton

Tweet by Laurie Garrett on Twitter

khlKaG7h_normal.jpg spacer.png
Laurie Garrett
⁦‪@Laurie_Garrett‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
NYC’s Health Commish has #COVID19
“I am grateful that my symptoms are quite mild, which I credit to my recent booster dose.
“I will be isolating at home for the #CDC -recc’ed 5-day period…After that, I will wear masks, to complete the 10-day intervl from the start of symptoms.” pic.twitter.com/XIO1dQDeMn
10/30/22, 1:40 PM

Joseph Thornton

Tweet by Michael Okun on Twitter

YPbCAmgI_normal.jpg spacer.png
Michael Okun
⁦‪@MichaelOkun‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
If you see someone in your practice who ‘fears disease progression’ with Parkinson or other neurological diseases two learning points. 1- identify and treat anxiety proactively, 2- address and work on helping them in self efficacy. Nice read: content.iospress.com/articles/journ…
10/22/22, 10:26 AM

Joseph Thornton

Tweet by Eric Topol on Obesity mechanism

kHgDk5TV_normal.png spacer.png
Eric Topol
⁦‪@EricTopol‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
The mechanism by which time-restricted eating limits obesity (in mice)
science.org/doi/10.1126/sc…
⁦‪@DamienLagarde‬⁩ ⁦‪@kazaklab‬⁩ ⁦‪@ScienceMagazine‬⁩ ⁦‪@ScienceVisuals‬⁩
re:
science.org/doi/10.1126/sc…
⁦‪@JoeBass91471540‬⁩ and colleagues pic.twitter.com/iVqHsgvAy8
10/20/22, 4:02 PM

Joseph Thornton

Tweet by Michael Okun on gfap in ftd

YPbCAmgI_normal.jpg spacer.png
Michael Okun
⁦‪@MichaelOkun‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Plasma GFAP/NfL ratio promising biomarker candidate to discriminate fronto-temporal dementia subtype FTLD-tau from FTLD-TDP; may possibly classify most patients with sporadic FTLD, whose pathology cannot be determined in life. Cool new study! ja.ma/3ENaa21 pic.twitter.com/KnLUm1qeBo
10/18/22, 8:00 AM

Joseph Thornton